USV is a 60-year-old company based in Mumbai with close to $500 million in revenue, mostly from the diabetic and cardiac segments. Among the top 15 companies in India, USV has a presence in over 60 countries with more than 100 satisfied customers and exports close to $100 million; with over 100 product approvals worldwide and more than 30 DMFs filed globally, the company offers value-added products in oral solids, injectables (PFS, vials), ophthalmics, biosimilars (pegfilgrastim) and peptides.

No comments available.
Leave your rating & comment